HomeProductsBioactive CompoundsCytoskeletonIntegrinAtn-161
Chemical structure of CAS 262438-43-7

Atn-161

In Stock•Starting at $21 for 1 mg•Purity ≥ 98%
CAS No.262438-43-7
MDL No.N/A
MFC23H35N9O8S
MW597.60
InChI KeyMMHDBUJXLOFTLC-WOYTXXSLSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$21In Stock
10 mg98%$69In Stock
25 mg98%$117In Stock
50 mg98%$161In Stock
100 mg98%$225In Stock
250 mg98%$380In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.262438-43-7
Product NameAtn-161

Biological Targets

ITGB1·ITGA5·ITGB3·ITGAV

Associated Conditions

Central Nervous System Neoplasm·renal cell carcinoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo.

Investigative ophthalmology & visual science • Vol. 52, Issue 10 • 2011
PMID: 21813636DOI: 10.1167/iovs.10-7097

Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

Clinical & experimental metastasis • Vol. 27, Issue 3 • 2010
PMID: 20339907PMC: PMC3053599DOI: 10.1007/s10585-010-9316-1

Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 14, Issue 7 • 2008
PMID: 18381955DOI: 10.1158/1078-0432.CCR-07-4530

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

Gut • Vol. 56, Issue 6 • 2007
PMID: 17170016PMC: PMC1954843DOI: 10.1136/gut.2006.114314

Documentation

Similar Products